Core Viewpoint - Astrana Health, Inc. (ASTH) shows significant upside potential with a mean price target of $49.56, indicating a 97.3% increase from the current price of $25.12 [1] Price Targets and Analyst Consensus - The average price target consists of nine estimates ranging from a low of $36.00 to a high of $70.00, with a standard deviation of $12.39, suggesting variability in analyst opinions [2] - The lowest estimate indicates a potential increase of 43.3%, while the highest suggests a 178.7% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about ASTH's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, two estimates have been revised upward, leading to a 46.4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - ASTH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

Core Insights - Autoliv, Inc. (ALV) is expected to report quarterly earnings of $2.07 per share, reflecting a 10.7% increase year-over-year, with revenues projected at $2.63 billion, a 0.8% increase from the previous year [1] - Analysts have revised the consensus EPS estimate upward by 0.7% over the past 30 days, indicating a collective reassessment of projections [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [3] Financial Metrics - Analysts estimate 'Net Sales- Seatbelt Products and Other' to reach $839.37 million, indicating a -2.2% change year-over-year [5] - 'Net Sales- Airbags, Steering Wheels and Other' is projected at $1.76 billion, reflecting a +0.5% change from the prior year [5] - 'Net Sales- Americas' is expected to be $855.27 million, showing a -4.2% change from the previous year [5] - 'Net Sales- Europe' is forecasted at $751.53 million, indicating a -1.2% change year-over-year [6] - 'Net Sales- Asia excl. China' is estimated to reach $499.63 million, reflecting a +3.4% change [6] - 'Net Sales- China' is projected at $488.36 million, indicating a +4.4% change from the prior year [6] Stock Performance - Autoliv shares have increased by +5.6% over the past month, compared to a +5% increase in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]

Core Viewpoint - Analysts project that Huntington Bancshares (HBAN) will report quarterly earnings of $0.34 per share, reflecting a year-over-year increase of 13.3% and revenues of $1.98 billion, up 9.2% from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 1.2%, indicating a collective reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [3]. Key Metrics Forecast - Analysts estimate the 'Efficiency Ratio' to be 60.4%, slightly improved from 60.8% a year ago [5]. - The 'Average Balance - Total earning assets' is projected at $191.10 billion, compared to $178.06 billion last year [5]. - The 'Tier 1 Leverage Ratio' is expected to be 8.4%, down from 8.8% a year ago [5]. - The 'Regulatory Tier 1 risk-based capital ratio' is estimated at 12.0%, slightly lower than the 12.1% reported in the same quarter last year [6]. Revenue Projections - 'Total Non-Interest Income' is expected to reach $520.55 million, up from $491.00 million in the same quarter last year [6]. - 'Mortgage banking income' is projected at $33.96 million, compared to $30.00 million a year ago [7]. - 'Customer deposit and loan fees' are expected to be $88.58 million, up from $83.00 million last year [7]. - 'Payments and cash management revenue' is forecasted at $162.96 million, compared to $154.00 million last year [8]. - 'Wealth and asset management revenue' is estimated at $103.61 million, up from $90.00 million a year ago [8]. - 'Capital markets and advisory fees' are expected to reach $76.17 million, compared to $73.00 million last year [9]. - 'Net interest income - FTE' is projected at $1.47 billion, up from $1.33 billion a year ago [9]. - 'Leasing revenue' is expected to be $15.53 million, down from $19.00 million last year [9]. Stock Performance - Huntington Bancshares shares have increased by 8.7% over the past month, outperforming the Zacks S&P 500 composite's 5% increase, with a Zacks Rank 2 (Buy) indicating expected outperformance in the near term [11].

Core Insights - Analysts project that The Charles Schwab Corporation (SCHW) will report quarterly earnings of $1.08 per share, reflecting a 48% year-over-year increase. Revenues are expected to reach $5.67 billion, marking a 20.8% increase from the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised upward by 2.2%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Key Financial Metrics - Analysts estimate 'Net Revenues - Net interest revenue' at $2.73 billion, a 26.5% increase from the previous year [5]. - 'Net Revenues - Other' is projected to be $212.08 million, reflecting a 3.2% decrease from the prior year [5]. - 'Net Revenues - Bank deposit account fees' are expected to reach $243.02 million, indicating a significant increase of 58.8% from the prior year [5]. - 'Net Revenues - Asset management and administration fees' are forecasted at $1.56 billion, a 12.9% increase year-over-year [6]. - Total client assets are projected to reach $10,444.09 billion, up from $9,407.50 billion a year ago [6]. Client Activity and Assets - 'Clients' Daily Average Trades (DATs)' are expected to be 7.15 million, compared to 5.49 million in the previous year [7]. - 'Average Interest Earning Assets' are projected to be $421.33 billion, slightly up from $418.97 billion year-over-year [7]. - 'Average Client Assets - Total managed investing solutions' are estimated at $686.27 million, compared to $635.92 million in the same quarter last year [8]. - 'Average Client Assets - Mutual Fund OneSource and other no-transaction-fee funds' are expected to reach $349.81 million, up from $338.20 million year-over-year [8]. - 'Average Client Assets - Schwab equity and bond funds, ETFs, and CTFs' are projected at $652.93 million, compared to $565.85 million last year [9]. - 'Average Client Assets - Schwab money market funds' are expected to be $651.07 million, up from $523.67 million in the same quarter last year [9]. - 'Net new client assets' are estimated at $95.09 billion, compared to $74.20 billion a year ago [10]. Stock Performance - Shares of Charles Schwab have increased by 4.2% over the past month, compared to a 5% increase in the Zacks S&P 500 composite [11].

Core Viewpoint - Analysts project that Regions Financial (RF) will report quarterly earnings of $0.56 per share, reflecting a year-over-year increase of 7.7% and revenues of $1.85 billion, up 7.1% from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 1.5% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Financial Metrics - Analysts expect the 'Net interest margin (FTE)' to reach 3.6%, up from 3.5% in the same quarter last year [5]. - The 'Efficiency Ratio' is projected at 56.9%, compared to 57.6% a year ago [5]. - The 'Common Equity Tier 1 ratio' is anticipated to be 10.7%, an increase from 10.4% year-over-year [5]. Asset and Income Projections - The 'Average Balance - Total earning assets' is expected to be $139.69 billion, up from $137.07 billion last year [6]. - 'Non-performing assets' are projected at $899.10 million, compared to $862.00 million a year ago [6]. - 'Total Non-Interest Income' is likely to reach $621.40 million, up from $545.00 million last year [8]. - 'Net Interest Income' is expected to be $1.20 billion, slightly up from $1.19 billion year-over-year [8]. Additional Financial Insights - The consensus estimate for 'Net interest income, taxable equivalent basis' stands at $1.24 billion, compared to $1.20 billion last year [9]. - 'Wealth management income' is estimated at $127.46 million, up from $122.00 million in the same quarter of the previous year [9]. - Regions Financial shares have returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +5% change [9].

Core Viewpoint - Analysts project that American Express (AXP) will report quarterly earnings of $3.86 per share, reflecting a year-over-year increase of 10.6%, with revenues expected to reach $17.69 billion, an 8.3% increase from the same quarter last year [1] Earnings Estimates - There have been no revisions in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [1][2] Key Metrics Projections - The consensus estimate for 'Book value per common share' is $44.84, up from $39.26 in the same quarter last year [4] - 'Risk-Based Capital - Common Equity Tier 1' is projected to be 10.5%, slightly down from 10.8% in the same quarter of the previous year [4] Commercial Services Metrics - 'Commercial Services - Card Member Loans - Total loans' are expected to reach $32.53 billion, compared to $28.62 billion in the same quarter last year [5] - 'Commercial Services - Card Member loans - Average Loans' is projected at $31.83 billion, up from $28.03 billion in the same quarter last year [5] International Card Services Metrics - 'International Card Services - Card Member loans - consumer and small business - Average loans' is forecasted to be $17.98 billion, compared to $16.84 billion in the same quarter last year [6] - 'International Card Services - Card Member loans - consumer and small business - Total loans' is expected to reach $18.50 billion, up from $17.27 billion a year ago [6] U.S. Consumer Services Metrics - 'U.S. Consumer Services - Card Member loans - Total loans' is projected at $92.66 billion, compared to $84.96 billion in the same quarter last year [7] - 'Card billed business (Network volumes)' is expected to reach $465.80 billion, up from $440.60 billion a year ago [7] Average Card Member Loans - 'Average Card Member loans' is expected to be $141.10 billion, compared to $128.32 billion in the same quarter last year [8] - 'Total Card Member loans' is projected at $143.69 billion, up from $130.85 billion in the same quarter last year [8] Non-Interest Revenues - 'Total non-interest revenues' are projected to reach $13.40 billion, compared to $12.60 billion in the same quarter last year [9] Stock Performance - Shares of American Express have returned +9.1% over the past month, outperforming the Zacks S&P 500 composite's +5% change [10]

Core Viewpoint - PepsiCo is expected to report a decline in quarterly earnings and revenues, with earnings per share projected at $2.03, down 11% year-over-year, and revenues forecasted at $22.37 billion, a decrease of 0.6% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.1% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Net Revenue- PBNA (PepsiCo Beverages North America)' to reach $6.84 billion, reflecting a year-over-year increase of 0.5% [5]. - 'Net Revenue- PFNA (PepsiCo Foods North America)' is estimated at $6.40 billion, indicating a significant year-over-year increase of 1040.2% [5]. - 'Net Revenue- LatAm Foods' is expected to be $2.50 billion, showing a year-over-year decline of 17.8% [5]. Stock Performance - PepsiCo shares have increased by 3.2% over the past month, compared to a 5% increase in the Zacks S&P 500 composite [6]. - With a Zacks Rank of 3 (Hold), PepsiCo is anticipated to closely follow overall market performance in the near term [6].

Wall Street analysts expect Netflix (NFLX) to post quarterly earnings of $7.05 per share in its upcoming report, which indicates a year-over-year increase of 44.5%. Revenues are expected to be $11.05 billion, up 15.6% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a ...

Core Viewpoint - Abbott (ABT) is expected to report quarterly earnings of $1.25 per share, reflecting a 9.7% increase year-over-year, with revenues projected at $11.07 billion, a 6.7% increase compared to the previous year [1]. Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [2]. Key Metrics Forecast - Analysts predict 'Net sales- Nutrition' to reach $2.24 billion, indicating a 4.3% increase from the prior year [4]. - The consensus for 'Net sales- Medical Devices- Diabetes Care' is $1.94 billion, reflecting a 17.5% year-over-year change [4]. - 'Net sales- Diagnostics' is expected to reach $2.22 billion, showing a 1% increase from the previous year [4]. - 'Net sales- Established Pharmaceuticals' is forecasted at $1.37 billion, a 6.1% increase year-over-year [5]. - 'Net sales- Diagnostics- U.S.' is estimated at $832.19 million, indicating a 2.5% increase [5]. - 'Net sales- Diagnostics- International' is projected to be $1.38 billion, reflecting a 0.1% increase [5]. - 'Net sales- Nutrition- International' is expected to reach $1.26 billion, a 3.5% year-over-year change [6]. - 'Net sales- Nutrition- U.S.' is forecasted at $985.20 million, indicating a 5.6% increase [6]. - 'Net sales- Medical Devices- Neuromodulation- International' is estimated at $53.47 million, reflecting a 4.8% increase [7]. - 'Net sales- Medical Devices- Rhythm Management- U.S.' is projected at $312.05 million, indicating a 6.9% increase [7]. - 'Net sales- Medical Devices- Rhythm Management- International' is expected to reach $334.64 million, reflecting a 6.2% year-over-year change [8]. - 'Net sales- Medical Devices- Structural Heart- U.S.' is forecasted at $304.28 million, indicating a 17.9% increase [8]. Stock Performance - Abbott shares have decreased by 2.7% over the past month, contrasting with the Zacks S&P 500 composite's 4% increase, but the company holds a Zacks Rank 2 (Buy), suggesting expected outperformance in the near term [8].

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short- term price performance of a stock. While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examin ...